-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4955)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2020 (publication date) through Apr 1, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Du QH, Zhang CJ, Li WH, Mu Y, Xu Y, Lowe S, Han L, Yu X, Wang SY, Li Y, Li J. Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation. World J Gastroenterol 2020; 26(21): 2810-2820 [PMID: 32550756 DOI: 10.3748/wjg.v26.i21.2810] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i21/2810.htm |
| Number | Citing Articles |
| 1 |
Na Jiang, Jing Zhang, Jian Ping, Lieming Xu. Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.938856
|
| 2 |
Chan Mo, Shuwen Xie, Ting Zeng, Yuqi Lai, Sha Huang, Chuying Zhou, Weixin Yan, Shaohui Huang, Lei Gao, Zhiping Lv. Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation. Phytomedicine 2021; 84: 153524 doi: 10.1016/j.phymed.2021.153524
|
| 3 |
D. V. Garbuzenko. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine 2022; 21(3): 154 doi: 10.20538/1682-0363-2022-3-154-165
|
| 4 |
Xin Zhao, Lingyu Li, Shuang Li, Jinyu Liu, Hongya Wang, Yulin Lin, Dayong Cai. Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3. European Journal of Pharmacology 2022; 929: 175115 doi: 10.1016/j.ejphar.2022.175115
|